About
Technology
Issues
FAQ
Links
Official Page
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.